Goldman Sachs Group Inc 4 D Molecular Therapeutics, Inc. Put Options Transaction History
Goldman Sachs Group Inc
- $780 Billion
- Q3 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding FDMT
# of Institutions
133Shares Held
40.4MCall Options Held
66.4KPut Options Held
38.3K-
Black Rock Inc. New York, NY4.9MShares$53.1 Million0.0% of portfolio
-
Bvf Inc San Francisco, CA4.63MShares$50.2 Million2.11% of portfolio
-
Ra Capital Management, L.P. Boston, MA4.56MShares$49.5 Million0.66% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.58MShares$27.9 Million0.0% of portfolio
-
Novo Holdings Hellerup, G72MShares$21.7 Million1.36% of portfolio
About 4D Molecular Therapeutics, Inc.
- Ticker FDMT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 32,382,400
- Market Cap $351M
- Description
- 4D Molecular Therapeutics, Inc., a clinical-stage gene therapy company, develops product candidates using its adeno-associated viruses vectors. It develops a portfolio of gene therapy product candidates focuses in three therapeutic areas: ophthalmology, cardiology, and pulmonology. The company has three product candidates that are in clinical tr...